3 excellent ASX growth shares analysts rate as buys

These ASX growth shares have been tipped as buys…

| More on:
A man with a wide, eager smile on his face holds up three fingers.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking to add some growth shares to your portfolio when the market reopens?

If you are, three ASX growth shares that could be worth considering are listed below. Here's what you need to know about them:

Allkem Ltd (ASX: AKE)

The first ASX growth share to consider is Allkem. It is one of the world's largest lithium miners with projects in Argentina, Australia, and North America. From these projects, the company is aiming to grow its production in a manner that allows it to maintain a 10% share of global lithium supply over the long term. And with lithium prices at such high levels and tipped to remain strong in the coming years due to demand outstripping supply, Allkem appears well-placed to grow its earnings and potentially start paying dividends.

Macquarie's analysts are bullish on Allkem and have an outperform rating and $21.00 price target on its shares.

Aristocrat Leisure Limited (ASX: ALL)

Another ASX growth share that has been tipped as a buy is Aristocrat Leisure. It is one of the world's leading gaming technology companies with a portfolio of world class pokie machines and a growing digital business. The former continues to win market share thanks to their popularity with casinos and players. Combined with the strong recurring revenues being generated by digital/mobile games such as Raid and its potential expansion into the real money gaming market, the company has been tipped to continue its solid earnings growth over the coming years.

Morgans is positive on the company and has an add rating and $43.00 price target on its shares.

ResMed Inc. (ASX: RMD)

A third and final growth share that has been named as a buy is ResMed. It is a sleep treatment-focused medical device company that has been tipped to continue its strong growth over the coming years. This is thanks to its world class product portfolio, a major competitor recall, and its massive global market opportunity. In respect to the latter, management estimates that there are 1 billion people impacted by sleep apnoea worldwide, with only ~20% of these sufferers currently diagnosed. As education around sleep disorders grows and more sufferers are diagnosed, demand for ResMed's products is likely to increase.

Goldman Sachs is bullish on ResMed and has a buy rating and $36.80 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

$100 Australian notes on top of each other.
Growth Shares

Where to invest $10,000 into ASX shares in July

Analysts are raving about these shares. But why are they buys?

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX growth shares to buy this month: experts

These stocks are expected to have a strong next few years…

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Growth Shares

3 ASX growth shares to buy before the next bull market

These shares could fare well in the next bull market. Here's what analysts are tipping as buys.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

3 no-brainer ASX shares to buy with $200 right now

You don't need a brain to see that these shares could be top picks right now.

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX growth stocks worth buying with $7,000 in your portfolio today

These stocks are all historic market beaters.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

3 ASX 200 shares with huge growth potential in the next decade

Analysts think these growth shares could be in the buy zone in July.

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.
Growth Shares

Where I'd invest $5,000 into ASX 300 growth shares

These stocks have excellent growth potential.

Read more »

a woman sits at a computer with a satisfied expression on her face in a white room with greenery outside her window.
Growth Shares

The ASX growth stock up 10% this year with more room to move

This broker believes there’s still more in the tank for this telecommunications company 

Read more »